Tag: Incorporated

Multiple Tobacco Brands Partnering with 22nd Century to Expand Availability and Awareness of VLN Based Reduced Nicotine Content Products 

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Bio Based Propylene Glycol Market size & share revenue was valued at approximately USD 4.53 Billion in 2024 and is expected to reach USD 4.73 Billion in 2025 and is expected to reach around USD 7.03 Billion by 2034, at a CAGR of 4.5% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Archer Daniels Midland (ADM), BASF SE, Dow Inc., DuPont Tate & Lyle Bio Products, Huntsman International, Cargill Incorporated, Oleon NV, Ashland Global, LyondellBasell Industries, Repsol, SK Global Chemical, P&G Chemicals, Global Bio-Chem Technology Group, ExxonMobil Corporation, Stepan Company, Corbion N.V., Sinopec (China Petroleum & Chemical Corp.), Mitsubishi Chemical Corporation, Shell Chemicals & Others.

NORTH BERGEN, NJ, July 16, 2025 (GLOBE NEWSWIRE) -- Free Flow, Inc. (OTC PK: FFLO), which is incorporated in the state of Delaware as Free Flow USA, Inc., today announced that the Company’s Accurate Investments, Inc subsidiary has entered into a contract to purchase a real estate investment property in New Jersey with existing and arranged highly-accredited tenants that would pay an approximate triple net lease amount of over $1,800,000 per annum against long term leases.

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

DALLAS, July 15, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX), the parent holding company for Veritex Community Bank, today announced a date change for release of its second quarter 2025 earnings results. Veritex will now release its second quarter 2025 earnings results before the opening of the market on Friday, July 18, 2025. The earnings release will be available on Veritex’s website, https://ir.veritexbank.com/.

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase common stock in an underwritten public offering. Gain expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or the warrants offered in the offering. All of the securities are being offered by the Company.

DALLAS, July 15, 2025 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce its preliminary operating results for the first quarter of its 2026 fiscal year (quarter ended June 30, 2025) and its first quarter 2026 earnings release and conference call schedule.